IS MORE BETTER

[1] APPLEBAUM FR, 1978, CANCER, V41, P1059

[2] ARIEL IM, 1962, SURGERY, V51, P583

[3] BUCKNER CD, 1972, CANCER, V29, P357, DOI 10.1002/1097-0142(197202)29:2<357::AID-CNCR2820290215>3.0.CO

[4] 2-M

[5] CORNBLEET MA, 1981, CANCER TREAT REP, V65, P241

[6] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594

[7] GREEN JA, 1980, B J CL PHARM, V9, P522

[8] THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) : 1281 - 1288

[9] HRYNIUK WM, 1986, J CLIN ONCOL

[10] LEVIN L, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P112

[1] APPLEBAUM FR, 1978, CANCER, V41, P1059

[2] ARIEL IM, 1962, SURGERY, V51, P583

[3] BUCKNER CD, 1972, CANCER, V29, P357, DOI 10.1002/1097-0142(197202)29:2<357::AID-CNCR2820290215>3.0.CO

[4] 2-M

[5] CORNBLEET MA, 1981, CANCER TREAT REP, V65, P241

[6] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594

[7] GREEN JA, 1980, B J CL PHARM, V9, P522

[8] THE IMPORTANCE OF DOSE INTENSITY IN CHEMOTHERAPY OF METASTATIC BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (11) : 1281 - 1288

[9] HRYNIUK WM, 1986, J CLIN ONCOL

[10] LEVIN L, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P112